Showing results (2071-2080 of 2,189) with videos related to

Sort By:
Pageof 219
European Heart Journal|September 11, 2019
Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registryEmmanuel Sorbets, Kim M Fox, Yedid Elbez, et al.
The American Journal of Cardiology|July 17, 2007
Long-term effect of perindopril on coronary atherosclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PERSPECTIVE] study)Gastón A Rodriguez-Granillo, Jeroen Vos, Nico Bruining, et al.
Cancer Research|September 13, 2011
A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancerEmily M Fox, Todd W Miller, Justin M Balko, et al.
Nature Microbiology|December 12, 2018
A multicomponent toxin from Bacillus cereus incites inflammation and shapes host outcome via the NLRP3 inflammasomeAnukriti Mathur, Shouya Feng, Jenni A Hayward, et al.
Plos One|January 31, 2025
Practice patterns on the management of secondary hyperparathyroidism in the United States: Results from a modified Delphi panelDavid E Henner, Beatrice Drambarean, Teresa M Gerbeling, et al.
Environmental Science & Technology|September 30, 2014
Speciation and reactivity of uranium products formed during in situ bioremediation in a shallow alluvial aquiferDaniel S Alessi, Juan S Lezama-Pacheco, Noémie Janot, et al.
JACC. Cardiovascular Imaging|April 18, 2016
CMR Guidance for Recanalization of Coronary Chronic Total OcclusionChiara Bucciarelli-Ducci, Dominique Auger, Carlo Di Mario, et al.
ACS Infectious Diseases|May 22, 2026
Legionella pneumophila Encodes a Peptidoglycan Recycling Machinery Critical for Survival within MacrophagesSushanta Ratna, Aastha Acharya, Miranda E Roland, et al.
Nanomaterials (Basel, Switzerland)|April 30, 2021
Fluorescently Labeled Cellulose Nanofibers for Environmental Health and Safety StudiesIlabahen Patel, Jeremiah Woodcock, Ryan Beams, et al.
Lancet (London, England)|June 1, 2000
Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT)W E Boden, W H van Gilst, R G Scheldewaert, et al.
Pageof 219